[1]
V. Shapovalov and O. Sichkarenko, “Forensic and pharmaceutical risks in the activities of healthcare facilities in the context of the spread of coronavirus disease (COVID-19) from the position of pharmaceutical law”, SSPMLP, vol. 1, no. 1, pp. 1–9, Aug. 2021.